4-aminopyridine has been researched along with dexfenfluramine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, SL; Michelakis, ED; Nelson, DP; Reeve, HL; Tolarova, S; Weir, EK | 1 |
Hong, Z; Kelly, RF; Lang, IM; Murar, J; Nelson, DP; Rezaie-Majd, S; Varghese, A; Weir, EK | 1 |
2 other study(ies) available for 4-aminopyridine and dexfenfluramine
Article | Year |
---|---|
Dexfenfluramine elevates systemic blood pressure by inhibiting potassium currents in vascular smooth muscle cells.
Topics: 4-Aminopyridine; Animals; Arteries; Blood Pressure; Calcium; Calcium Channels; Dexfenfluramine; Electrophysiology; Enzyme Inhibitors; In Vitro Techniques; Ion Channel Gating; Ketanserin; Male; Membrane Potentials; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1999 |
Increased release of serotonin from rat ileum due to dexfenfluramine.
Topics: 4-Aminopyridine; Animals; Caffeine; Calcium; Chromatography, High Pressure Liquid; Cytosol; Dexfenfluramine; Fluoxetine; Hypertension, Pulmonary; Ileum; Male; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2004 |